[Immunocompetence and immunotherapy of patients with cancer of the kidney and bladder].
作者信息
Mokhort V A, Grigorovich N A, Strotskiĭ A V, Mavrichev A S
出版信息
Urol Nefrol (Mosk). 1986 Jan-Feb(1):66-74.
PMID:3513423
Abstract
摘要
相似文献
1
[Immunocompetence and immunotherapy of patients with cancer of the kidney and bladder].
Urol Nefrol (Mosk). 1986 Jan-Feb(1):66-74.
2
Lymphocyte-mediated cytotoxicity in patients with renal and transitional cell carcinoma receiving BCG.接受卡介苗治疗的肾细胞癌和移行细胞癌患者的淋巴细胞介导的细胞毒性
Natl Cancer Inst Monogr. 1978 Dec(49):343-5.
3
Immunology of bladder cancer.
Minn Med. 1980 Mar;63(3):173-4.
4
5
BCG immunotherapy of bladder cancer: 20 years on.膀胱癌的卡介苗免疫疗法：二十年回顾。
Lancet. 1999 May 15;353(9165):1689-94. doi: 10.1016/S0140-6736(98)07422-4.
6
[Immunodiagnosis and immunotherapy of bladder tumors].
Urol Nefrol (Mosk). 1984 Jan-Feb(1):69-72.
7
Effect of BCG immunotherapy on cell-mediated cytotoxicity in bladder cancer patients following surgical treatment.
Tumori. 1981 May-Jun;67(3):177-82. doi: 10.1177/030089168106700303.
8
[Zeta chain level of T and NK cells in patients with renal-cell carcinoma and bladder cancer and its clinical significance].[肾细胞癌和膀胱癌患者T细胞和NK细胞的ζ链水平及其临床意义]
Zhonghua Zhong Liu Za Zhi. 2004 Mar;26(3):158-60.
9
Bacillus Calmette-Guérin-pulsed dendritic cells stimulate natural killer T cells and gammadeltaT cells.卡介苗脉冲树突状细胞刺激自然杀伤T细胞和γδT细胞。
Int J Urol. 2007 Jun;14(6):532-8; discussion 538. doi: 10.1111/j.1442-2042.2006.01697.x.
10
CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity.在原位膀胱癌模型中，CpG疗法优于卡介苗，并能产生CD4+ T细胞免疫。
J Immunother. 2008 Jan;31(1):34-42. doi: 10.1097/CJI.0b013e3181587d29.
Zotero 插件